Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil

Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil

Background: Cancer patients present a distinct vulnerability to COVID-19. It is unclear if chemotherapy could accentuate the overall risk in these patients. Methods: We performed a retrospective analysis linking COVID-19 data and oncological information systems to compare lethality in patients under...

Full description

Bibliographic Details
Main Authors: Mateus Bringel Oliveira Duarte, Frederico Leal, Juliana Luz Passos Argenton, José Barreto Campello Carvalheira
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
neoplasms
COVID-19
drug therapy
comorbidity
propensity score
Online Access:https://www.mdpi.com/2072-6694/12/12/3490

Internet

https://www.mdpi.com/2072-6694/12/12/3490

Similar Items